Evidence map›Paper›PMID 24210220›Full record

ArticleChemistry & biology2013

Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes.

Ciorsdaidh A Watts, Frances M Richards, Andreas Bender, Peter J Bond, Oliver Korb, Oliver Kern, Michelle Riddick, Paul Owen, Rebecca M Myers, Jordan Raff and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Chemistry & biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Mechanism and regulation of kinesin motors.Nature reviews. Molecular cell biology · 2025
    Review
  13. Looking Under the Hood at the Cytoskeletal Engine of Platelet Production.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Surviving the Storm: The Role of Poly- and Depolyploidization in Tissues and Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Ciorsdaidh A WattsDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK.
Frances M Richards
Andreas Bender
Peter J Bond
Oliver Korb
Oliver Kern
Michelle Riddick
Paul Owen
Rebecca M Myers
Jordan Raff
Fanni Gergely
Duncan I Jodrell
Steven V Ley
University of Cambridge · GBCancer Research UK · GBCancer Research UK Technology · GBCambridge Crystallographic Data Centre · GBUnilever (United Kingdom) · GBUniversity of Oxford · GB

Funding

Cancer Research UK 10530Cancer Research UK 15678Cancer Research UK 17043Cancer Research UK 6934
6 · The paper itself

Abstract

Centrosomes associate with spindle poles; thus, the presence of two centrosomes promotes bipolar spindle assembly in normal cells. Cancer cells often contain supernumerary centrosomes, and to avoid multipolar mitosis and cell death, these are clustered into two poles by the microtubule motor protein HSET. We report the discovery of an allosteric inhibitor of HSET, CW069, which we designed using a methodology on an interface of chemistry and biology. Using this approach, we explored millions of compounds in silico and utilized convergent syntheses. Only compound CW069 showed marked activity against HSET in vitro. The inhibitor induced multipolar mitoses only in cells containing supernumerary centrosomes. CW069 therefore constitutes a valuable tool for probing HSET function and, by reducing the growth of cells containing supernumerary centrosomes, paves the way for new cancer therapeutics.

Indexed as

Drug DesignAllosteric RegulationAntineoplastic AgentsCell Line, TumorCell ProliferationCentrosomeDose-Response Relationship, DrugDrug Screening Assays, AntitumorEnzyme InhibitorsHeLa CellsHumansKinesinsMCF-7 CellsModels, MolecularMolecular Structureortho-AminobenzoatesAntineoplastic AgentsCW069 compoundEnzyme InhibitorsKinesinsortho-AminobenzoatesPhenylalanine

Identifiers

PMID24210220
PMCPMC3898838
OpenAlexW2044798778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.